28521737|t|Validation of the German version of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire
28521737|a|Health benefits of the Mediterranean Diet (MD) have been shown in different at-risk populations. A German translation of the Mediterranean Diet Adherence Screener (MEDAS) from the PREvención con DIeta MEDiterránea (PREDIMED) consortium was used in the LIBRE study, investigating effects of lifestyle - intervention on women with BRCA1 / 2 mutations. The purpose of the present study is to validate the MEDAS German version. LIBRE is a multicentre (three university hospitals during this pilot phase), unblinded, randomized, controlled clinical trial. Women with a BRCA1 / 2 mutation of age 18 or over who provided written consent were eligible for the trial. As part of the assessment, all were given a full-length Food Frequency Questionnaire (FFQ) and MEDAS at baseline and after 3 months. Data derived from FFQ was compared to MEDAS in order to evaluate agreement or concordance between the two questionnaires. Additionally, the association of dietary intake biomarkers in the blood (β-carotene, omega-3, omega-6 and omega-9 fatty acids and high-sensitivity C-reactive protein (hsCRP)) with some MEDAS items was analyzed using t-Tests and a multivariate regression. The participants of the LIBRE pilot study were 68 in total (33 Intervention, 35 Control). Only participants who completed both questionnaires were included in this analysis (baseline: 66, month three: 54). The concordance between these two questionnaires varied between the items (Intraclass correlation coefficient of 0.91 for pulses at the highest and -0.33 for sugar-sweetened drinks). Mean MEDAS scores (sum of all items) were 9% higher than their FFQ counter-parts at baseline and 15% after 3 months. Higher fish consumption (at least 3 portions) was associated with lower omega-6 fatty acid levels (p = 0.026) and higher omega-3 fatty acid levels (p = 0.037), both results being statistically significant. We conclude that the German MEDAS in its current version could be a useful tool in clinical trials and in practice to assess adherence to MD. ClinicalTrials.gov, registered on March 12, 2014, identifier: NCT02087592. World Health Organization Trial Registration, registered on 3 August 2015, identifier: NCT02087592.
28521737	0	10	Validation	T062	C1519941
28521737	18	24	German	T171	C0017477
28521737	25	32	version	T170	C0333052
28521737	40	77	Mediterranean Diet Adherence Screener	T170	C0282574
28521737	79	84	MEDAS	T170	C0282574
28521737	86	99	questionnaire	T170	C0034394
28521737	100	115	Health benefits	T081	C0086387
28521737	123	141	Mediterranean Diet	T061	C1138412
28521737	143	145	MD	T061	C1138412
28521737	166	175	different	T080	C1705242
28521737	176	195	at-risk populations	T098	C0242444
28521737	199	205	German	T171	C0017477
28521737	206	217	translation	T170	C0040712
28521737	225	262	Mediterranean Diet Adherence Screener	T170	C0282574
28521737	264	269	MEDAS	T170	C0282574
28521737	280	313	PREvención con DIeta MEDiterránea	T170	C0282574
28521737	315	323	PREDIMED	T170	C0282574
28521737	325	335	consortium	T097	C1513822
28521737	352	363	LIBRE study	T062	C2603343
28521737	365	378	investigating	T169	C1292732
28521737	379	389	effects of	T080	C1704420
28521737	390	399	lifestyle	T054	C0023676
28521737	402	414	intervention	T058	C1273869
28521737	418	423	women	T098	C0043210
28521737	429	434	BRCA1	T049	C1511022
28521737	437	448	2 mutations	T049	C1511024
28521737	454	461	purpose	T169	C1285529
28521737	477	482	study	T062	C2603343
28521737	489	497	validate	T062	C1519941
28521737	502	507	MEDAS	T170	C0282574
28521737	508	514	German	T171	C0017477
28521737	515	522	version	T170	C0333052
28521737	524	529	LIBRE	T093	C1708333
28521737	535	546	multicentre	T093	C1708333
28521737	554	574	university hospitals	T073,T093	C0020028
28521737	593	598	phase	T079	C0205390
28521737	601	649	unblinded, randomized, controlled clinical trial	T062	C0206035
28521737	651	656	Women	T098	C0043210
28521737	664	669	BRCA1	T049	C1511022
28521737	672	682	2 mutation	T049	C1511024
28521737	705	713	provided	T052	C1999230
28521737	714	729	written consent	T058	C0811746
28521737	735	743	eligible	T080	C1548635
28521737	752	757	trial	T062	C0008976
28521737	774	784	assessment	T058	C0220825
28521737	803	843	full-length Food Frequency Questionnaire	T170	C2986698
28521737	845	848	FFQ	T170	C2986698
28521737	854	859	MEDAS	T170	C0282574
28521737	863	871	baseline	T081	C1442488
28521737	892	896	Data	T078	C1511726
28521737	897	904	derived	T080	C1441547
28521737	910	913	FFQ	T170	C2986698
28521737	918	926	compared	T052	C1707455
28521737	930	935	MEDAS	T170	C0282574
28521737	948	956	evaluate	T058	C0220825
28521737	957	966	agreement	T054	C0680240
28521737	970	981	concordance	T054	C0680240
28521737	998	1012	questionnaires	T170	C0034394
28521737	1032	1043	association	T080	C0439849
28521737	1047	1061	dietary intake	T040	C1286104
28521737	1062	1072	biomarkers	T201	C0005516
28521737	1080	1085	blood	T031	C0005767
28521737	1087	1097	β-carotene	T109,T121,T127	C0053396
28521737	1099	1106	omega-3	T109,T121,T123	C0015689
28521737	1108	1115	omega-6	T109,T123	C0133860
28521737	1120	1139	omega-9 fatty acids	T121	C4056511
28521737	1144	1179	high-sensitivity C-reactive protein	T059	C0973334
28521737	1181	1186	hsCRP	T059	C0973334
28521737	1199	1204	MEDAS	T170	C0282574
28521737	1205	1210	items	T062,T170	C0871509
28521737	1215	1223	analyzed	T062	C0936012
28521737	1230	1237	t-Tests	T170	C0871472
28521737	1244	1256	multivariate	T062,T170	C0010101
28521737	1257	1267	regression	T081	C0023733
28521737	1273	1285	participants	T098	C0679646
28521737	1293	1310	LIBRE pilot study	T062	C0031928
28521737	1332	1344	Intervention	T058	C1273869
28521737	1349	1356	Control	T096	C0009932
28521737	1364	1376	participants	T098	C0679646
28521737	1381	1390	completed	T078	C1556116
28521737	1396	1410	questionnaires	T170	C0034394
28521737	1416	1424	included	T169	C0332257
28521737	1433	1441	analysis	T062	C0936012
28521737	1443	1451	baseline	T081	C1442488
28521737	1479	1490	concordance	T054	C0680240
28521737	1509	1523	questionnaires	T170	C0034394
28521737	1543	1548	items	T062,T170	C0871509
28521737	1550	1584	Intraclass correlation coefficient	T081	C0392762
28521737	1611	1618	highest	T080	C1522410
28521737	1633	1655	sugar-sweetened drinks	T168	C0016452
28521737	1658	1675	Mean MEDAS scores	T033	C3533236
28521737	1688	1693	items	T062,T170	C0871509
28521737	1703	1709	higher	T080	C0205250
28521737	1721	1724	FFQ	T170	C2986698
28521737	1742	1750	baseline	T081	C1442488
28521737	1775	1781	Higher	T080	C0205250
28521737	1782	1798	fish consumption	T039	C1947907
28521737	1811	1819	portions	T081	C0560666
28521737	1825	1840	associated with	T080	C0332281
28521737	1841	1846	lower	T052	C2003888
28521737	1847	1865	omega-6 fatty acid	T109,T123	C0133860
28521737	1866	1872	levels	T080	C0441889
28521737	1889	1895	higher	T080	C0205250
28521737	1896	1914	omega-3 fatty acid	T109,T121,T123	C0015689
28521737	1915	1921	levels	T080	C0441889
28521737	1940	1947	results	T034	C0456984
28521737	1954	1979	statistically significant	T081	C0237881
28521737	1984	1992	conclude	T078	C1707478
28521737	2002	2008	German	T171	C0017477
28521737	2009	2014	MEDAS	T170	C0282574
28521737	2022	2029	current	T079	C0521116
28521737	2030	2037	version	T170	C0333052
28521737	2049	2055	useful	T080	C3827682
28521737	2064	2079	clinical trials	T062	C0008976
28521737	2099	2105	assess	T058	C0184514
28521737	2106	2115	adherence	T169	C1510802
28521737	2119	2121	MD	T061	C1138412
28521737	2198	2223	World Health Organization	T093	C0043237